LyRIC indeterminate response and Immune-mediated pseudoprogression of diffuse large B-cell lymphoma following polatuzumab-based salvage therapy

被引:4
|
作者
Lee, Alexander T. J. [1 ]
Attygale, Ayoma D. [1 ]
Sharma, Rajaei K. [2 ]
Iyengar, Sunil [1 ]
El-Sharkawi, Dima [1 ]
Chau, Ian [1 ]
Vroobel, Katherine M. [1 ]
Fotiadis, Nicos [1 ]
Khan, Nasir [1 ]
Butterfield, Nicholas [1 ]
Wotherspoon, Andrew [1 ]
Cunningham, David [1 ]
Sharma, Bhupinder [1 ]
机构
[1] Royal Marsden NHS Fdn Trust, London, England
[2] Univ Exeter, Med Sch, Exeter, Devon, England
关键词
diffuse large B cell lymphoma; polatuzumab; pseudo-progression;
D O I
10.1111/bjh.16679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E248 / E251
页数:4
相关论文
共 50 条
  • [31] The molecular rationale for the combination of polatuzumab vedotin plus rituximab in diffuse large B-cell lymphoma
    Kawasaki, Natsumi
    Nishito, Yukari
    Yoshimura, Yasushi
    Yoshiura, Shigeki
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (02) : 245 - 255
  • [32] Cost-effectiveness of polatuzumab vedotin in relapsed or refractory diffuse large B-cell lymphoma
    Patel, Kishan K.
    Isufi, Iris
    Kothari, Shalin
    Foss, Francine
    Huntington, Scott
    LEUKEMIA & LYMPHOMA, 2020, 61 (14) : 3387 - 3394
  • [33] Efficacy of Salvage Radiotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
    Wang, S.
    Chen, J. Y.
    Cao, W.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E471 - E472
  • [34] Efficacy of salvage radiotherapy for relapsed/refractory diffuse large B-cell lymphoma
    Wang, Shu-Bei
    Chen, Jia-Yi
    Zhao, Wei-Li
    Kirova, Youlia M.
    Cao, Wei-Guo
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1019 - 1026
  • [35] Salvage therapy R-DAOx in patients with relapsed or refractory diffuse large B-CELL lymphoma
    Mappa, S.
    Rigacci, L.
    Nassi, L.
    Puccini, B.
    Alterini, R.
    Carrai, V.
    Bernardi, F.
    Bosi, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 532 - 532
  • [36] Immune targeted therapy for diffuse large B cell lymphoma
    Zheng, Yaxin
    Si, Junqi
    Yuan, Tian
    Ding, Sa
    Tian, Chen
    BLOOD SCIENCE, 2021, 3 (04): : 136 - 148
  • [37] Targeting HDACs for diffuse large B-cell lymphoma therapy
    Wu, Chunyan
    Song, Qiao
    Gao, Sophie
    Wu, Shaoling
    SCIENTIFIC REPORTS, 2024, 14 (01)
  • [38] Therapy of elderly patients with diffuse large B-cell lymphoma
    Pfreundschuh, M.
    ONKOLOGIE, 2011, 34 : 88 - 88
  • [39] Targeting HDACs for diffuse large B-cell lymphoma therapy
    Chunyan Wu
    Qiao Song
    Sophie Gao
    Shaoling Wu
    Scientific Reports, 14
  • [40] Therapy for diffuse large B-cell lymphoma: getting personal
    Cheson, Bruce D.
    LANCET, 2013, 381 (9880): : 1793 - 1794